http://biz.yahoo.com/ic/news/515.htmlThe latest news on the Biotechnology industry from Yahoo! Financeen-usFri, 27 Nov 2009 15:58:57 Etc/GMThttp://us.news2.yimg.com/us.yimg.com/p/fi/pr/40197.gifhttp://finance.yahoo.com14417http://us.rd.yahoo.com/finance/external/mfool/rss/SIG=131o4jup1/*http%3A//www.fool.com/investing/high-growth/2009/11/27/biotech-bargains-for-your-portfolio.aspx?source=eptyholnk303100&logvisit=y&npu=yyahoo_finance/2757966048Fri, 27 Nov 2009 15:58:57 Etc/GMThttp://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/bw/091127/20091127005029.html?.v=2DELRAY BEACH, Fla.----XenaCare Holdings, Inc. , a company specializing in the marketing and retail distribution of consumer healthcare products, has announced today that is has become a national sponsor of the Arthritis Foundation at the National Proud Sponsor level.yahoo_finance/3718520390Fri, 27 Nov 2009 14:21:00 Etc/GMThttp://us.rd.yahoo.com/finance/external/cbsm/rss/SIG=12c3984gt/*http%3A//www.marketwatch.com/news/story/renault-dubai-qlt-focus/story.aspx?guid=%7B20AB6614%2D9C0D%2D47F4%2D8368%2DA948A44A6498%7D&siteid=yhoofA roundup of financial and business news breaking before the opening bell on Wall Street.yahoo_finance/892501805Fri, 27 Nov 2009 13:38:00 Etc/GMThttp://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/bw/091127/20091127005021.html?.v=1SUMMIT, N.J.----Celgene Corporation today announced its presentation at the NASDAQ OMX 23rd Investor Program on Tuesday, December 1, 2009 at 8:30 a.m. GMT will be webcast live and will be available in the investor relations section of the company’s Web site at www.celgene.com.yahoo_finance/993282077Fri, 27 Nov 2009 12:30:00 Etc/GMThttp://us.rd.yahoo.com/finance/external/tsmfe/rss/SIG=12p2j0oon/*http%3A//www.thestreet.com/_yahoo/story/10633325/1/biotech-stock-mailbag-targacept.html?cm_ven=YAHOO&cm_cat=FREE&cm_ite=NAyahoo_finance/1597461405Fri, 27 Nov 2009 11:00:00 Etc/GMThttp://us.rd.yahoo.com/finance/external/pssa/rss/SIG=13360skco/*http%3A//seekingalpha.com/article/175426-cytrx-announces-first-of-two-positive-developments-ahead?source=yahooyahoo_finance/3019513173Thu, 26 Nov 2009 10:17:07 Etc/GMThttp://us.rd.yahoo.com/finance/external/pssa/rss/SIG=12gamtpgq/*http%3A//seekingalpha.com/article/175397-financing-drug-discovery-recent-deals?source=yahooyahoo_finance/4170407548Thu, 26 Nov 2009 08:41:16 Etc/GMThttp://us.rd.yahoo.com/finance/external/pssa/rss/SIG=12mfa4ill/*http%3A//seekingalpha.com/article/175391-sinovac-adds-vaccine-capacity-by-forming-jv?source=yahooyahoo_finance/4180002126Thu, 26 Nov 2009 08:05:08 Etc/GMThttp://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/ap/091125/us_la_jolla_pharma_options.html?.v=1La Jolla Pharmaceutical Co. said Wednesday its shareholders did not support a proposal to dissolve the company, and it will consider other options.yahoo_finance/4031584093Wed, 25 Nov 2009 21:56:44 Etc/GMThttp://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/prnews/091125/la17508.html?.v=1Heska Corporation ; , a leading provider of advanced diagnostic and specialty products to the veterinary industry, announced today agreements with Roche Diagnostics Corporation for the supply of blood gas products and affiliated consumables for the veterinary market.yahoo_finance/672662993Wed, 25 Nov 2009 21:11:00 Etc/GMThttp://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/prnews/091125/sf17425.html?.v=1Onyx Pharmaceuticals, Inc. today announced that the company will host two investor events in December:yahoo_finance/2234474949Wed, 25 Nov 2009 21:00:00 Etc/GMThttp://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/bw/091125/20091125005708.html?.v=1SAN DIEGO----La Jolla Pharmaceutical Company today announced that its Special Meeting of Stockholders, which was originally convened on October 30, 2009 and subsequently adjourned twice, was adjourned for a third time on November 24, 2009 and has not been scheduled to be reconvened.yahoo_finance/1639392661Wed, 25 Nov 2009 20:38:00 Etc/GMThttp://us.rd.yahoo.com/finance/external/mfool/rss/SIG=1308c22gi/*http%3A//www.fool.com/investing/value/2009/11/25/still-enjoying-those-acquisitions-pfizer.aspx?source=eptyholnk303100&logvisit=y&npu=yyahoo_finance/4217598925Wed, 25 Nov 2009 19:55:01 Etc/GMThttp://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/bw/091125/20091125005657.html?.v=1SOUTH SAN FRANCISCO, Calif.----Exelixis, Inc. announced today that Charles Butler, the company’s vice president, investor relations and corporate communications, will present at Piper Jaffray’s 21st Annual Healthcare Conference at 1:30 p.m.yahoo_finance/2963117252Wed, 25 Nov 2009 19:15:00 Etc/GMThttp://us.rd.yahoo.com/finance/external/cbsm/rss/SIG=12lf0vnc5/*http%3A//www.marketwatch.com/news/story/incyte-idera-move-novartis-deals/story.aspx?guid=%7B6909CE04%2D95A8%2D4E09%2DB0ED%2D420D9D8DCFC8%7D&siteid=yhoofShares of Incyte stand out in pre-holiday trading, rallying on a drug-development deal reached with Novartis.yahoo_finance/246196332Wed, 25 Nov 2009 19:02:00 Etc/GMThttp://us.rd.yahoo.com/finance/external/cbsm/rss/SIG=12mms70jp/*http%3A//www.marketwatch.com/news/story/incyte-shares-rally-novartis-deal/story.aspx?guid=%7BDDA7AD9C%2DFFEA%2D4F6A%2DA72C%2DF243996D259C%7D&siteid=yhoofIncyte shares gain on the financial potential from the company's drug-development and licensing deal with Novartis.yahoo_finance/2380305691Wed, 25 Nov 2009 17:28:00 Etc/GMThttp://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/ap/091125/us_human_genome_sciences_zalbin.html?.v=2Human Genome Sciences Inc. said Wednesday it has filed for marketing approval of its hepatitis C drug Zalbin. The Rockville, Md., company did not say when it expected a response to its biologics license application, which was submitted to the Food and Drug Administration.yahoo_finance/3079434443Wed, 25 Nov 2009 16:48:34 Etc/GMThttp://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/ap/091125/us_incyte_novartis.html?.v=1Drug developer Incyte Corp. on Wednesday licensed two potential drugs, including a treatment for myelofibrosis, to Swiss drugmaker Novartis AG In a deal that could be worth more than $1.3 billion.yahoo_finance/3309405111Wed, 25 Nov 2009 15:53:46 Etc/GMThttp://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/zacks/091125/27649.html?.v=1The U.S. Food and Drug Administration is expected to decide on whether to approve Provenge, a therapeutic vaccine by Dendreon for the treatment of prostate cancer in men, by May 1, 2010.yahoo_finance/407283354Wed, 25 Nov 2009 15:39:14 Etc/GMThttp://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/zacks/091125/27641.html?.v=1yahoo_finance/983570530Wed, 25 Nov 2009 15:10:28 Etc/GMT